Nutriband Inc. logo

Nutriband Inc.

NASDAQ:NTRB

Overview | Financials
Company Name Nutriband Inc.
Symbol NTRB
Currency USD
Price 3.91
Market Cap 30,627,617
Dividend Yield 0%
52-week-range 1.53 - 5.927
Industry Biotechnology
Sector Healthcare
CEO Mr. Gareth Sheridan
Website https://nutriband.com

An error occurred while fetching data.

About Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops

Related Stocks

Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc.

CRBP

42.72 USD

Oncternal Therapeutics, Inc. logo

Oncternal Therapeutics, Inc.

ONCT

8.8 USD

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

1.25 USD

Biomerica, Inc. logo

Biomerica, Inc.

BMRA

0.77 USD

Terns Pharmaceuticals, Inc. logo

Terns Pharmaceuticals, Inc.

TERN

5.06 USD

Financials

Numbers are in millions USD

Numbers are in millions USD